Es ist ein Fehler aufgetreten!
CVS Health Aktie
| 54.59 CHF | 0.25CHF | 0.46% |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 1.00 |
| Vanguard Group, Inc. (Subfiler) | 0.08 |
| The Vanguard Group, Inc. | 0.08 |
| State Street Corp. | 0.05 |
| Wellington Management Co. LLP | 0.03 |
| Vanguard Total Stock Market Index Fund | 0.03 |
| BlackRock Institutional Trust Co. NA | 0.03 |
| Capital Research & Management Co. (International Investors) | 0.02 |
| Dodge & Cox | 0.02 |
| Fidelity Management & Research Co. | 0.02 |
| Vanguard 500 Index Fund | 0.02 |
| BlackRock Fund Advisors | 0.02 |
| Vanguard Dividend Appreciation Index Fund | 0.01 |
| Aig Focused Dividend Strategy Fund | 0.01 |
| Delaware Value Fund | 0.01 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 217'800 | 243'000 | 250'000 | 246'000 | 295'000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 639'885'215'794'307.00 | 63'082'304'526'749.00 | 710'104.00 | 751'077'235'772'358.00 | 659'586'440'677'966.00 |
Bilanz (in Mio. EUR) - Aktiva
| 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 25'983 | 30'378 | 31'042 | 31'229 | 45'243 |
| Summe Anlagevermögen | 50'913 | 64'660 | 64'361 | 64'693 | 131'654 |
| Summe Aktiva | 74'252 | 93'657 | 94'462 | 95'131 | 198'210 |
Bilanz (in Mio. EUR) - Passiva
| 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 12'955 | 27'464 | 27'531 | 27'002 | 73'429 |
| Summe Fremdkapital | 36'289 | 56'415 | 57'628 | 57'436 | 139'667 |
| Summe Eigenkapital | 37'963 | 37'242 | 36'834 | 37'695 | 58'543 |
| Summe Passiva | 74'252 | 93'657 | 94'462 | 95'131 | 198'210 |
Adresse
| One CVS Drive, 02895 Woonsocket | |
| Telefon | 1.401.765.1500 |
| Internet | http://www.cvshealth.com |
Management
|
Alan M. Lotvin
Chief Transformation Officer & Executive VP |
|
Alecia A. DeCoudreaux
Independent Director |
|
Andrew J. Sussman
Executive VP & Associate Chief Medical Officer |
|
Anne M. Finucane
Independent Director |
|
C. David Brown
Independent Director |
|
Carol A. DeNale
Treasurer & Senior Vice President |
|
Colleen M. McIntosh
Secretary, SVP & Assistant General Counsel |
|
David Falkowski
Chief Compliance Officer & Senior Vice President |
|
David L. Casey
Chief Diversity Officer & VP-Workforce Strategies |
|
David Wyatt Dorman
Chairman |
|
Derica W. Rice
Executive VP-CVS Health & President-CVS Caremark |
|
Edward J. Ludwig
Independent Director |
|
Eva C. Boratto
Chief Financial Officer & Executive Vice President |
|
Fernando G. Aguirre
Independent Director |
|
J. David Joyner
Executive Vice President-Sales & Account Services |
|
James D. Clark
Chief Accounting Officer, Senior VP & Controller |
|
Jane F. Barlow
Associate Chief Medical Officer |
|
Jean-Pierre Millon
Independent Director |
|
John P. Kennedy
Chief Tax Officer & Senior Vice President |
|
Jonathan C. Roberts
Chief Operating Officer & Executive Vice President |
|
Joshua M. Flum
EVP-Enterprise Strategy & Corporate Development |
|
Karen S. Lynch
EVP & President-Aetna Business Unit |
|
Larry J. Merlo
President, CEO & Non-Independent Director |
|
Lisa G. Bisaccia
Chief Human Resources Officer & Executive VP |
|
Mark T. Bertolini
Director |
|
Mary L. Schapiro
Independent Director |
|
Melissa A. Schulman
Senior Vice President-Government & Public Affairs |
|
Nancy-Ann M. DeParle
Independent Director |
|
Norman de Greve
Chief Marketing Officer & Senior VP |
|
Per G. H. Lofberg
Executive Vice President |
|
Richard J. Swift
Independent Director |
|
Richard M. Bracken
Independent Director |
|
Roger N. Farah
Independent Director |
|
Thomas M. Moriarty
Chief Policy & External Affairs Officer, EVP |
|
Tony Lee White
Independent Director |
|
Troyen A. Brennan
Chief Medical Officer & Executive Vice President |
|
Valerie C. Haertel
Senior Vice President-Investor Relations |
|
William C. Weldon
Independent Director |
